- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PureTech Health PLC (PRTCY)
PureTech Health PLC stock price live, this page displays OTC PRTCY stock exchange data. View the PRTCY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the PureTech Health PLC real time stock price chart below.
What Is the PureTech Health PLC Stock Price Today?
The PureTech Health PLC stock price today is 15.55.
What Is the Stock Symbol for PureTech Health PLC?
The stock symbol for PureTech Health PLC is "PRTCY."
What Stock Exchange Does PureTech Health PLC Trade On?
PureTech Health PLC is listed and trades on the OTC Markets stock exchange.
Is PureTech Health PLC a Good Stock to Buy?
Determining whether PureTech Health PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRTCY quote. (ISIN: US7462371060)
What Is the PureTech Health PLC Stock Price Today?
The PureTech Health PLC stock price today is 15.55.
What Is the Stock Symbol for PureTech Health PLC?
The stock symbol for PureTech Health PLC is "PRTCY."
What Stock Exchange Does PureTech Health PLC Trade On?
PureTech Health PLC is listed and trades on the OTC Markets stock exchange.
Is PureTech Health PLC a Good Stock to Buy?
Determining whether PureTech Health PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRTCY quote. (ISIN: US7462371060)
OTC Markets
Currency in USD
15.55
-1.07(-6.44%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.55
15.93
52 wk Range
14.50
19.92
PRTCY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.5515.93
52 wk Range
14.5019.92
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PRTCY Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
46.00
Upside
+195.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Form 13G PureTech Health plc For: 11 May- Investing.com
- Form 13G PureTech Health plc For: 11 May
- Investing.com
- Form 6K PureTech Health PLC For: 29 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 46.00
(+195.82% Upside)
PureTech Health PLC Earnings Call Summary for H2/2025
- PureTech Health posted $110.1M net loss in FY2025 vs. $27.8M income in 2024; revenue fell 2.1% to $4.7M amid operational restructuring.
- Operating loss improved 27.6% to $98.5M; cash position declined 24.5% YoY to $277.1M, with operational runway extending through 2028.
- Company announced voluntary Nasdaq delisting while maintaining London Stock Exchange listing to reduce costs and streamline operations.
- Stock dropped 2.98% to $17.60 in pre-market trading despite 9% YTD gains; analysts set $46 price target suggesting significant upside potential.
- CEO emphasized strategic focus on capital efficiency and investments in founded entities like Celea Therapeutics and Gallop Oncology for growth.
Last Updated: 2026-04-29, 10:34 a/m
Read Full TranscriptEarnings
Latest Release
Jun 23, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare PRTCY to Peers and Sector
Metrics to compare | PRTCY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPRTCYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.6x | −1.3x | −0.4x | |
PEG Ratio | 0.01 | 0.15 | 0.00 | |
Price/Book | 1.3x | 3.0x | 2.6x | |
Price / LTM Sales | 84.7x | 14.8x | 2.9x | |
Upside (Analyst Target) | 176.8% | 329.8% | 56.8% | |
Fair Value Upside | Unlock | 7.1% | 8.9% | Unlock |
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and LYT-200, a fully human IgG4 monoclonal antibody. The company also develops SPT-300, a Glyphed oral prodrug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development and oral therapies based on defined bacterial consortia that is in phase 3 clinical stage. PureTech Health plc was incorporated in 2015 and is based in Boston, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the PureTech Health (PRTCY) Stock Price Today?
The PureTech Health stock price today is 15.55 USD.
What Stock Exchange Does PureTech Health Trade On?
PureTech Health is listed and trades on the OTC Markets.
What Is the Stock Symbol for PureTech Health?
The stock symbol for PureTech Health is "PRTCY."
What Is the PureTech Health Market Cap?
As of today, PureTech Health market cap is 3.79B USD.
What Is PureTech Health's Earnings Per Share (TTM)?
The PureTech Health EPS (TTM) is -0.46.
When Is the Next PureTech Health Earnings Date?
PureTech Health will release its next earnings report on Aug 27, 2026.
From a Technical Analysis Perspective, Is PRTCY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has PureTech Health Stock Split?
PureTech Health has split 0 times.
How Many Employees Does PureTech Health Have?
PureTech Health has 90 employees.
What is the current trading status of PureTech Health (PRTCY)?
As of Jul 28, 2026, PureTech Health (PRTCY) is trading at a price of 15.55 USD, with a previous close of 16.62 USD. The stock has fluctuated within a day range of 15.55 USD to 15.93 USD, while its 52-week range spans from 14.50 USD to 19.92 USD.
What Is PureTech Health (PRTCY) Price Target According to Analysts?
The average 12-month price target for PureTech Health is 46.00 USD, with a high estimate of 46 USD and a low estimate of 46 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +195.82% Upside potential.
What Is the PRTCY After Hours Price?
PRTCY's last after hours stock price is 17.41 USD, the stock has decreased by 0.68, or 4.06%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.